Nearly $30 million in tax incentive awards are expected to add 1,519 new life sciences jobs in Massachusetts, with about 52% ...

Health insurers defended the steep rate increases they have planned as an unfortunate but necessary response to rising ...

BIO International Convention 2025-- At the BIO International Convention 2025 in Boston, King Faisal Specialist Hospital & ...

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class ...

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, accelerating a push into experimental cardiovascular therapies.

The pavilion, run by the Korea Trade-Investment Promotion Agency (KOTRA), features 58 companies in cooperation with five ...

Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, signed a Memorandum of Understanding (MoU) with ...

The hearing captured the tension and complexity of reining in health care costs that are among the highest in the nation, as insurers, providers and prescription drug companies all point the ...

Boston-based Verve is a rare example of a gene editing company targeting a disease that affects a large population, offering ...